40 Stocks Moving In Wednesday's Mid-Day Session

Gainers

• Blink Charging Co. BLNK shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
• Eleven Biotherapeutics, Inc. EBIO shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
• Flanigan's Enterprises, Inc. BDL shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
• Borqs Technologies, Inc. BRQS rose 15.8 percent to $8.05 after reporting Q1 results.
• Abaxis, Inc. ABAX jumped 15.3 percent to $82.75. Zoetis Inc. ZTS announced plans to acquire Abaxis for $83 per share in cash.
• 21Vianet Group, Inc. VNET gained 15.1 percent to $6.33.
• Gemphire Therapeutics Inc. GEMP rose 13.8 percent to $6.27.
• Enphase Energy, Inc. ENPH gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
• PetIQ Inc PETQ shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
• NF Energy Saving Corporation NFEC climbed 11.6 percent to $2.399.
• Allied Healthcare Products, Inc. AHPI surged 11.4 percent to $3.0643.
• Boot Barn Holdings, Inc. BOOT gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
• Ascena Retail Group, Inc. ASNA rose 10.9 percent to $3.16.
• Sea Limited SE gained 10.1 percent to $11.71 after reporting Q1 results.
• GEE Group, Inc. JOB climbed 7.9 percent to $2.61 following Q2 results.
• The ONE Group Hospitality, Inc. STKS gained 7.6 percent to $2.41 after reporting Q1 results.
• Biolinerx Ltd/S ADR BLRX rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-stage biopharmaceutical company focused on oncology and immunology said it was granted a patent from the European Patent Office for its BL-8040 with cytarabine for the treatment of acute myeloid leukemia.
• Micro Focus International plc MFGP shares rose 7 percent to $18.28 after the company issued strong revenue forecast for the first fiscal half of 2018.
• Calumet Specialty Products Partners, L.P. CLMT gained 6.3 percent to $8.445 after reporting Q1 results.
• Macy's, Inc. M rose 5.8 percent to $31.66 after the company reported stronger-than-expected results for its first quarter and lifted guidance.
• Imprimis Pharmaceuticals Inc IMMY rose 5.2 percent to $2.52 after reporting a first-quarter sales beat.
• ChemoCentryx, Inc. CCXI gained 5.2 percent to $12.02. Canaccord Genuity initiated coverage on ChemoCentryx with a Buy rating.

Check out these big penny stock gainers and losers

Losers

• Evolus, Inc. EOLS shares tumbled 30 percent to $10.25. The lifestyle aesthetics company said the FDA issued a Complete Response Letter which cited deficiencies which were related to Chemistry, Manufacturing, and Controls processes which is not related to clinical or non-clinical matters.
• Purple Innovation, Inc. PRPL shares dropped 22.2 percent to $7.81 after reporting Q1 results.
• Cemtrex, Inc. CETX dipped 19.5 percent to $2.10. Cemtrex posted Q2 earnings of $0.04 per share on sales of $20.6 million.
• Biocept, Inc. BIOC shares declined 15.7 percent to $0.1851 after the company reported Q1 results.
• BSQUARE Corporation BSQR dropped 14.9 percent to $3.15 following Q1 earnings.
• Social Reality, Inc. SRAX declined 14.8 percent to $3.80 after reporting a first-quarter sales miss.
• Netlist, Inc. NLST shares dropped 14.8 percent to $0.159 after reporting mixed Q1 results.
• DPW Holdings, Inc. DPW dropped 14.4 percent to $0.76. DPW priced its 7.7 million share direct offering at $0.78 per share.
• Omeros Corporation OMER fell 14.4 percent to $20.91.
• Red Violet, Inc. RDVT dropped 14.2 percent to $8.53 after climbing 75.31 percent on Tuesday.
• Netshoes (Cayman) Limited NETS fell 13.8 percent to $2.47. JP Morgan downgraded Netshoes from Overweight to Underweight.
• ENDRA Life Sciences Inc. NDRA dropped 12.3 percent to $2.1501 after reporting Q1 results.
• Verastem, Inc. VSTM fell 11.8 percent to $4.62 after announcing a $35 million common stock offering.
• BIO-key International, Inc. BKYI dropped 10.6 percent to $2.10. BIO-key posted a Q1 loss of $0.30 per share on sales of $841,000.
• Novume Solutions, Inc. NVMM shares fell 8.9 percent to $2.45.
• Euro Tech Holdings Company Limited CLWT shares fell 7.5 percent to $4.16 after rising 40.62 percent on Tuesday.
• XTL Biopharmaceuticals Ltd. XTLB fell 4.5 percent to $1.91 after climbing 10.50 percent on Tuesday.
• CELYAD SA/ADR CYAD shares fell 4.4 percent to $29.37 after the company reported launch of 1.8 million share offering.